These findings raise an interesting possibility that overexpression of EZH2 is not sufficient to drive mammary tumorigenesis and that persistent activation of EZH2 by cyclin E/CDK2-dependent phosphorylation may be a prerequisite for tumor development. Here, CDK2 is linked to neoplasm.